Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Depreciation & Amortization (CF) (2021 - 2025)

Roivant Sciences' Depreciation & Amortization (CF) history spans 5 years, with the latest figure at $691000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 94.54% year-over-year to $691000.0; the TTM value through Dec 2025 reached $2.7 million, down 87.89%, while the annual FY2025 figure was $14.1 million, 36.15% down from the prior year.
  • Depreciation & Amortization (CF) reached $691000.0 in Q4 2025 per ROIV's latest filing, down from $921000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $16.8 million in Q4 2023 to a low of $691000.0 in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $6.0 million, with a median of $4.9 million recorded in 2024.
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 205.35% in 2022, then tumbled 94.54% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $4.2 million in 2021, then surged by 205.35% to $12.9 million in 2022, then soared by 30.28% to $16.8 million in 2023, then decreased by 24.78% to $12.6 million in 2024, then crashed by 94.54% to $691000.0 in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Depreciation & Amortization (CF) are $691000.0 (Q4 2025), $921000.0 (Q3 2025), and $1.1 million (Q2 2025).